CO4990935A1 - Derivados de tiazol - Google Patents

Derivados de tiazol

Info

Publication number
CO4990935A1
CO4990935A1 CO98077474A CO98077474A CO4990935A1 CO 4990935 A1 CO4990935 A1 CO 4990935A1 CO 98077474 A CO98077474 A CO 98077474A CO 98077474 A CO98077474 A CO 98077474A CO 4990935 A1 CO4990935 A1 CO 4990935A1
Authority
CO
Colombia
Prior art keywords
zero
alkyl
cycloalkyl
aryl
hydrogen
Prior art date
Application number
CO98077474A
Other languages
English (en)
Inventor
Alig Leo
Edenhofer Albrecht
Kurt Hilpert
Thomas Weller
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of CO4990935A1 publication Critical patent/CO4990935A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/48—Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

Compuestos de fórmula IEn los que R1 es R2 es En los que Het es un sistema de anillo heterocíclico de 5 a 8 miembros, que está sustituido con R9 y en el que puede estar presente un átomo adicional de N, O ó S en el anillo, además del átomo de nitrógeno, R3 es hidrógeno, alquilo, cicloalquilo, arilo, aralquilo o heteroarilo; R4 es hidrógeno, alquilo, cicloalquilo, arilo o heteroarilo;R5 , R6 , R7 y R8 son cada uno independientemente hidrógeno, alquilo o cicloalquilo, o R7 y R8 junto con los átomos de nitrógeno a los que están unidos forman un anillo heterocíclico de 5 a 8 miembros que puede estar sustituido con alquilo; R9 es R10 es arilo, aralquilo, heterociclilo o un a-aminoácido unido a través del grupo amino, de "a" a "i" son cero o números positivos enteros, de modo que "a" y "b" son cada uno independientemente de cero a 4, "d" es cero ó 1, siendo "f" igual a cero cuando "d" es igual a cero, la suma de "c", "d" y "e" es ³ 1 y £ 4, "f" y "h" son cada uno independientemente cero ó 1, siendo "i" diferente de cero cuando "h"=1, la suma de "g", "h" y "i" es ³ 2 y £ 5; Y sus sales y ésteres farmacéuticamente utilizables.
CO98077474A 1998-01-02 1998-12-30 Derivados de tiazol CO4990935A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98100007 1998-01-02

Publications (1)

Publication Number Publication Date
CO4990935A1 true CO4990935A1 (es) 2000-12-26

Family

ID=8231230

Family Applications (1)

Application Number Title Priority Date Filing Date
CO98077474A CO4990935A1 (es) 1998-01-02 1998-12-30 Derivados de tiazol

Country Status (29)

Country Link
US (1) US6001855A (es)
JP (1) JP3154982B2 (es)
KR (1) KR100312900B1 (es)
CN (1) CN1098849C (es)
AR (1) AR014211A1 (es)
AT (1) ATE217621T1 (es)
AU (1) AU718659B2 (es)
BR (1) BR9805750A (es)
CA (1) CA2257322C (es)
CO (1) CO4990935A1 (es)
DE (1) DE69805392T2 (es)
DK (1) DK0928793T3 (es)
ES (1) ES2176895T3 (es)
HK (1) HK1021733A1 (es)
HR (1) HRP980644B1 (es)
HU (1) HUP9803041A3 (es)
ID (1) ID21878A (es)
IL (1) IL127784A (es)
MA (1) MA26590A1 (es)
NO (1) NO312134B1 (es)
PE (1) PE20000116A1 (es)
PL (1) PL330620A1 (es)
PT (1) PT928793E (es)
RU (1) RU2166503C2 (es)
SG (1) SG72911A1 (es)
TR (1) TR199802766A2 (es)
UY (1) UY25335A1 (es)
YU (1) YU60998A (es)
ZA (1) ZA9811923B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4517454B2 (ja) * 2000-06-01 2010-08-04 宇部興産株式会社 ４−（１−フルオロエチル）チアゾール−５−カルボン酸アミド誘導体及び農園芸用の有害生物防除剤
US6451821B1 (en) * 2000-06-09 2002-09-17 Aventis Pharma S.A. Use of 2-aminothiazoline derivatives as inhibitors of inducible no-synthase
US6420566B2 (en) * 2000-06-09 2002-07-16 Aventis Pharma S.A. Pharmaceutical compositions containing a 4, 5-dihydro-1, 3-thiazol-2-ylamine derivative, novel derivatives and preparation thereof
WO2017095991A1 (en) * 2015-12-04 2017-06-08 Janssen Biotech, Inc. Treatment of retinal degeneration using progenitor cells

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0123741A1 (en) * 1983-04-26 1984-11-07 Shionogi & Co., Ltd. 2-Guanidino-4-hydroxymethylthiazole and derivatives thereof
IL95548A0 (en) * 1989-09-15 1991-06-30 Fujisawa Pharmaceutical Co Thiazole derivatives,processes for the preparation thereof and pharmaceutical composition containing the same
TW201303B (es) * 1990-07-05 1993-03-01 Hoffmann La Roche
NZ318926A (en) * 1995-08-30 1999-04-29 Searle & Co Alpha v beta 3 integrin (vitronectin) inhibitors or anatagonists derived from benzoic acid for treating diseases of cell adhesion
WO1997026250A1 (en) * 1996-01-16 1997-07-24 Merck & Co., Inc. Integrin receptor antagonists
DE69835430T2 (de) * 1997-05-30 2007-03-08 Takeda Pharmaceutical Co. Ltd. Sulfonamidderivate, ihre herstellung und verwendung

Also Published As

Publication number Publication date
JP3154982B2 (ja) 2001-04-09
AR014211A1 (es) 2001-02-07
CA2257322A1 (en) 1999-07-02
KR19990066903A (ko) 1999-08-16
SG72911A1 (en) 2000-05-23
CN1098849C (zh) 2003-01-15
PE20000116A1 (es) 2000-02-11
DE69805392T2 (de) 2002-12-19
ATE217621T1 (de) 2002-06-15
HK1021733A1 (en) 2000-06-30
RU2166503C2 (ru) 2001-05-10
CA2257322C (en) 2003-11-04
ES2176895T3 (es) 2002-12-01
JP2000053678A (ja) 2000-02-22
HUP9803041A2 (hu) 2000-04-28
AU718659B2 (en) 2000-04-20
PL330620A1 (en) 1999-07-05
DE69805392D1 (de) 2002-06-20
BR9805750A (pt) 2001-04-24
ZA9811923B (en) 2000-06-29
KR100312900B1 (ko) 2002-01-17
NO986160L (no) 1999-07-05
HU9803041D0 (en) 1999-02-01
DK0928793T3 (da) 2002-09-09
TR199802766A3 (tr) 1999-07-21
ID21878A (id) 1999-08-05
AU9614598A (en) 1999-07-22
TR199802766A2 (xx) 1999-07-21
HRP980644B1 (en) 2003-08-31
UY25335A1 (es) 2001-01-31
NO986160D0 (no) 1998-12-28
IL127784A (en) 2001-09-13
HRP980644A2 (en) 1999-10-31
YU60998A (sh) 2001-12-26
US6001855A (en) 1999-12-14
MA26590A1 (fr) 2004-12-20
IL127784A0 (en) 1999-10-28
PT928793E (pt) 2002-10-31
NO312134B1 (no) 2002-03-25
HUP9803041A3 (en) 2001-04-28
CN1227225A (zh) 1999-09-01

Similar Documents

Publication Publication Date Title
ES2192081T3 (es) Derivados de purina antivirales.
FI954105A (fi) Uusia 4-aminopyridiinejä, niiden valmistusmenetelmä sekä näitä yhdisteitä sisältäviä lääkkeitä
CO4990934A1 (es) Derivados de tiazol
ES2260933T3 (es) Derivados del acido de tiazolina.
NZ334548A (en) Azinyloxy, and phenoxy-diaryl-carboxylic acid derivatives, their preparation and use as mixed eta/etb endothelin receptor antagonists
ES2160106T3 (es) Derivados de la quinazolina.
CO4950561A1 (es) Derivados de ergolina
DK0541550T3 (da) Nye mellemprodukter, deres fremstilling og anvendelse
DK0488897T3 (da) Guanidinderivater, fremgangsmåde til fremstilling heraf samt farmaceutiske midler indeholdende disse
DK105290D0 (da) Terapeutisk polyamin-amider
CO4990935A1 (es) Derivados de tiazol
FI842500A0 (fi) Foerfarande foer framstaellning av -karbolinderivat.
TW333532B (en) Benzopyrans
ES2109988T3 (es) Derivados cefalosporinicos.
ATE185813T1 (de) Tetrahydronaphthalin-peptidderivate
DE69201848D1 (de) Verfahren zum Härten von Gelatine.
CO5050293A1 (es) Bisindolilmaleimidas sustituidas
DK0582506T3 (da) Tetrahydronaphthalenderivater, fremgangsmåde til fremstilling deraf og terapeutisk anvendelse af disse
CO4900072A1 (es) Derivados de 1-carba-(detia)-cefalosporina
DE60011473D1 (de) Diazepinecarboxamidderivate, verfahren zu ihrer herstellung ,ihre verwendung als arzneimittel, pharmazeutische zubereitungen und ihre verwendung
ECSP993294A (es) 4- oxo-1,4- dihidro -3-quinoleincarboxamidas como agentes antivirales
GB1102765A (en) Ergolenyl-carboxylic acid amides
ECSP972262A (es) Derivados de 1-carba (detia)-cefalosporina
ECSP920824A (es) Herbicidas de aril-halogenoalquipirazoles substituidos
GR34820B (el) Μεθοδος παρασκευης παραγωγων φαινυλαμινοαιθονολης.